Kazuki Hayashi

Kazuki Hayashi

Auto-generated profile, based on publicly available information

Kazuki Hayashi

Department of Gastroenterology Nagoya City University East Medical Center Aichi Japan

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2012 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
INItaru Naitoh
Itaru Naitoh
KHKazuki Hayashi
Kazuki Hayashi
TNTakahiro Nakazawa
Takahiro Nakazawa
FOFumihiro Okumura
Fumihiro Okumura
KMKatsuyuki Miyabe
Katsuyuki Miyabe
TJTakashi Joh
Takashi Joh

15 May 2021 in Gut and Liver
Verified
Journal Article
Open access
PDF file
MYMichihiro Yoshida
Michihiro Yoshida
INItaru Naitoh
Itaru Naitoh
KHKazuki Hayashi
Kazuki Hayashi
NJNaruomi Jinno
Naruomi Jinno
YHYasuki Hori
Yasuki Hori
HKHiromi Kataoka
Hiromi Kataoka
Michihiro Yoshida, Itaru Naitoh, Kazuki Hayashi, Naruomi Jinno, Yasuki Hori, Makoto Natsume, Akihisa Kato, Kenta Kachi, Go Asano, Naoki Atsuta, Hidenori Sahashi, and Hiromi Kataoka. Gut and Liver 2021;15:476-85. https://doi.org/10.5009/gnl20238

1 March 2021 in Cancer Research
Verified
Journal Article
Open access
PDF file
YTYoshihiko Tasaki
Yoshihiko Tasaki
MSMiho Suzuki
Miho Suzuki
KKKeisuke Katsushima
Keisuke Katsushima
KSKeiko Shinjo
Keiko Shinjo
KIKenta Iijima
Kenta Iijima
YKYutaka Kondo
Yutaka Kondo
Overcoming drug resistance is one of the biggest challenges in cancer chemotherapy. In this study, we examine whether targeting the long noncoding RNA taurine upregulated gene 1 (TUG1) could be an effective therapeutic approach to overcome drug resistance in pancreatic ductal adenocarcinoma (PDAC). TUG1 was expressed at significantly higher levels across 197 PDAC tissues compared with normal pancreatic tissues. Overall survival of patients with PDAC who had undergone 5-FU–based chemotherapy was shorter in high TUG1 group than in low TUG1 group. Mechanistically, TUG1 antagonized miR-376b-3p and upregulated dihydropyrimidine dehydrogenase (DPD). TUG1 depletion induced susceptibility to 5-FU in BxPC-3 and PK-9 pancreatic cell lines. Consistently, the cellular concentration of 5-FU was significantly higher under TUG1-depleted conditions. In PDAC xenograft models, intravenous treatment with a cancer-specific drug delivery system (TUG1-DDS) and 5-FU significantly suppressed PDAC tumor growth compared with 5-FU treatment alone. This novel approach using TUG1-DDS in combination with 5-FU may serve as an effective therapeutic option to attenuate DPD activity and meet appropriate 5-FU dosage requirements in targeted PDAC cells, which can reduce the systemic adverse effects of chemotherapy. Significance: Targeting TUG1 coupled with a cancer-specific drug delivery system effectively modulates 5-FU catabolism in TUG1-overexpressing PDAC cells, thus contributing to a new combinatorial strategy for cancer treatment.

9 March 2017 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
YHYasuki Hori
Yasuki Hori
INItaru Naitoh
Itaru Naitoh
KHKazuki Hayashi
Kazuki Hayashi
TBTesshin Ban
Tesshin Ban
MNMakoto Natsume
Makoto Natsume
TJTakashi Joh
Takashi Joh

1 January 2009 in Cases Journal
Verified
Journal Article
Open access
PDF file
INItaru Naitoh
Itaru Naitoh
TNTakahiro Nakazawa
Takahiro Nakazawa
HOHirotaka Ohara
Hirotaka Ohara
TATomoaki Ando
Tomoaki Ando
KHKazuki Hayashi
Kazuki Hayashi
TJTakashi Joh
Takashi Joh
Inflammatory pseudotumor is rare benign mass composed of chronic inflammatory cell infiltration and proliferating fibrous tissue. Some cases of inflammatory pseudotumor show abundant infiltrating IgG4-positive plasma cells and obliterative phlebitis, which are the pathologic hallmarks of autoimmune pancreatitis.

15 February 2015 in Digestive Endoscopy
Verified
Journal Article
Closed access
PDF file
KMKatsuyuki Miyabe
Katsuyuki Miyabe
KHKazuki Hayashi
Kazuki Hayashi
TNTakahiro Nakazawa
Takahiro Nakazawa
HSHitoshi Sano
Hitoshi Sano
TYtomonori yamada
tomonori yamada
TJTakashi Joh
Takashi Joh